Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background And Aims: Adolescent polysubstance use has been associated with adverse social and health outcomes. Our aim was to measure rates and transitions to polysubstance use during adolescence and identify factors associated with initiation and discontinuation of polysubstance use.
Design: Prospective cohort study. Multistate Markov modelling was used to estimate rates and identify correlates of transitions between substance use states.
Setting And Participants: Adolescent-parent dyads (n = 1927; adolescents in grade 7, age ≈13 years) were recruited from Australian schools during 2010/11 (Wave 1). Adolescents were surveyed annually until 2016/17 (n = 1503; age ≈19 years; Wave 7) and parents were surveyed annually until 2014/15 (Wave 5).
Measurements: Alcohol, tobacco, cannabis and 3,4-methylenedioxymethamphetamine (MDMA) use outcomes were collected at Waves 3-7. Potential confounders were collected at Waves 1-6 and consisted of sex, anxiety and depression symptoms and externalizing problems, parental monitoring, family conflict and cohesion, parental substance use and peer substance use. Covariates were age and family socioeconomic status.
Findings: Few adolescents engaged in polysubstance use at earlier waves (Wave 3: 5%; Wave 4: 8%), but proportions increased sharply across adolescence (Waves 5-7: 17%, 24%, 36%). Rates of transitioning to polysubstance use increased with age, with few (<9%) adolescents transitioning out. More externalizing problems (odds ratio [OR] = 1.10; 99.6% confidence interval [CI] = 1.07-1.14), parental heavy episodic drinking (OR = 1.22; 99.6% CI = 1.07-1.40), parental illicit substance use (OR = 3.56; 99.6% CI = 1.43-8.86), peer alcohol use (OR = 5.68; 99.6% CI = 1.59-20.50) and peer smoking (OR = 4.18; 99.6% CI = 1.95-8.81) were associated with transitioning to polysubstance use.
Conclusions: Polysubstance use in Australia appears to be rare during early adolescence but more common in later adolescence with low rates of transitioning out. Externalizing problems and greater parental and peer substance use are risk factors for adolescent polysubstance use that may be suitable intervention targets.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/add.16468 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Latent Transition Analysis of Substance Use Patterns Among Early Adolescents in an Urban Community.
Subst Use Misuse
August 2025
Department of Psychology, Virginia Commonwealth University, Richmond, VA, US.
: The purpose of this study was to identify subgroups of early adolescents based on their history of initiation and recent substance use, examine changes in their subgroup membership across two waves, and evaluate whether sociodemographic characteristics were associated with longitudinal changes in substance use patterns. : Participants were 1,811 early adolescents (72% Black, 53% female) attending middle schools in neighborhoods with high rates of violence and residents with incomes below the federal poverty level. Latent class analysis identified subgroups of adolescents with different substance use patterns at two waves 3 months apart.
View Article and Find Full Text PDFUse of Illegally Manufactured Fentanyl in the United States: Current Trends.
Curr Addict Rep
December 2025
Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, FL, USA.
Purpose Of Review: As the overdose crisis evolves, it is important to monitor fentanyl consumption patterns. This review provides an overview of recent findings regarding illegally manufactured fentanyl (IMF) availability, use, and associated harms in the US.
Recent Findings: Availability of IMF has increased, especially in pill form, and the increasing adulteration of IMF with veterinary tranquilizers such as xylazine complicates overdose response.
Xylazine Withdrawal: A Case Report From the Intensive Care Unit to the Medical Ward.
Cureus
July 2025
Hospital Medicine, Northridge Hospital Medical Center, Los Angeles, USA.
Xylazine is a centrally acting alpha-2 adrenergic agonist commonly used with fentanyl in illicit drug mixtures, yet its withdrawal profile remains poorly characterized. We report a case of a 35-year-old man with polysubstance use, significant for fentanyl with xylazine and bipolar disorder. He presented with seizure-like activity and agonal breathing, requiring intensive care unit admission.
View Article and Find Full Text PDFCross sectional analysis of an addiction consultation service, substance co-use patterns, and receipt of medications for opioid use disorder during hospitalization.
J Subst Use Addict Treat
December 2024
Health, Homelessness, and Criminal Justice Lab, Hennepin Healthcare Research Institute, 701 Park Ave., Suite PP7.700, Minneapolis, MN 55415, USA; Division of General Internal Medicine, Department of Medicine, Hennepin Healthcare, 716 S 7(th) St, Minneapolis, MN 55415, USA.
Introduction: Despite effective medications for opioid use disorder (MOUD), treatment engagement remains low. As the overdose crisis is increasingly characterized by opioids co-used with other substances, it is important to understand whether existing models effectively support treatment for patients who use multiple substances. Hospital-based addiction consultation services (ACS) have shown promise at increasing MOUD initiation and treatment engagement, but the effectiveness for patients with specific co-use patterns remains unknown.
View Article and Find Full Text PDFLost in transition: A protocol for a retrospective, longitudinal cohort study for addressing challenges in opioid treatment for transition-age adults.
PLoS One
August 2024
Department of Population Health, New York University Grossman School of Medicine, New York, New York, United States of America.
Article Synopsis
- There's a significant rise in opioid use disorders (OUD) among young adults (ages 18-25) in the U.S., especially among those on Medicaid, highlighting the need for improved treatment systems for this vulnerable group.
- Current treatment methods, particularly pharmacotherapy, are effective, but many young adults are not receiving the medications they need, leading to poor treatment outcomes.
- This study will analyze treatment practices and outcomes using data from 65,000 TA adults in New York to understand the factors affecting treatment quality and inform better healthcare decisions for patients and providers.